Перейти к содержанию

Nuwellis, Inc. (NUWE) stock: revenue, earnings & dividend

Nuwellis, Inc. (NUWE, Nasdaq): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener NUWE · Nasdaq Medizintechnik & Messgeräte US-MN

Key figures

Fiscal year
2025
Revenue
8.27 m $
Revenue growth
-5.4 %
Revenue growth 5y (p.a.)
2.1 %
Net income
-17.52 m $
Net margin
-211.9 %
Operating margin
-134.3 %
Earnings per share (diluted)
-25.39 $
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
6.12 m $
Equity
2.62 m $
Equity ratio
42.9 %
Return on equity
-667.7 %
Cash
1.09 m $
Operating cash flow
-10.81 m $
Free cash flow
-10.9 m $
Shares outstanding
540,912

History

Revenue by fiscal year

2016 1.29 m $
2017 3.55 m $
2018 5 m $
2019 5.51 m $
2020 7.44 m $
2021 7.92 m $
2022 8.54 m $
2023 8.86 m $
2024 8.74 m $
2025 8.27 m $

Net income by fiscal year

2016 -15.79 m $
2017 -13.38 m $
2018 -17.03 m $
2019 -18.11 m $
2020 -15.84 m $
2021 -19.55 m $
2022 -14.53 m $
2023 -20.21 m $
2024 -11.17 m $
2025 -17.52 m $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20258.27 m $-17.52 m $-25.39 $–-10.81 m $
20248.74 m $-11.17 m $-353.30 $–-9.59 m $
20238.86 m $-20.21 m $-360.06 $–-17.94 m $
20228.54 m $-14.53 m $-83.55 $–-15.15 m $
20217.92 m $-19.55 m $-285.36 $–-17.84 m $
20207.44 m $-15.84 m $-10.67 $–-16.57 m $
20195.51 m $-18.11 m $––-16.37 m $
20185 m $-17.03 m $––-14.56 m $
20173.55 m $-13.38 m $––-11.92 m $
20161.29 m $-15.79 m $––-16.29 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)